University of Illinois at Chicago Exclusive License Amendment SECOND AMENDMENT TO RESPIRERX -UNIVERSITY OF ILLINOIS EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • January 23rd, 2023 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations
This Second Amendment (“Amendment 2”) to the Exclusive License Agreement is made and entered into as of the December 15, 2022 (“Effective Date”), by and between the Board of Trustees of the University of Illinois, a body corporate and politic of the State of Illinois, and having a place of business at 352 Henry Administration Building, 506 S. Wright St., Urbana, Illinois 61801 (“University”) and RespireRx Pharmaceuticals Inc., a Delaware corporation, and having a place of business at 126 Valley Road, Suite C, Glen Rock, New Jersey 07452 (“Licensee”). Collectively, University and LICENSEE may be referred to as “the Parties.” Individually, each may be referred to as a “Party.”
